Substance use in a Dutch migraine cohort compared with the general population
Headache: The Journal of Head and Face Pain · 2024
DOI: 10.1111/head.14663 ↗Kurz gefasst
Fachartikel in der Zeitschrift Headache: The Journal of Head and Face Pain, 2024. Verfasst von Thomas C van den Hoek und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands. Hauptthemen laut MEDLINE: Migraine Disorders, Substance-Related Disorders. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
To evaluate self‐reported substance user profiles for individuals with migraine and compare these to the general population.
Background
There is increasing attention to lifestyle influences such as substance use as presumed migraine triggers.
Methods
Data on substance use were collected by survey in a large migraine cohort and from the biannual survey in the general Dutch population for substances. A representative cohort of Dutch patients with migraine ( n = 5176) and the Dutch general population ( n = 8370) was included. Patients with migraine were subdivided into episodic (EM) and chronic migraine (CM). Substance consumption was compared between the general population and patients with migraine, and between migraine subgroups after standardization for sex and level of education.
Results
Included patients with migraine were 83.4% female (4319/5176) and had a mean (standard deviation) age of 44.8 (11.3) years. Patients with migraine reported less illicit drug use (odds ratio [OR] 0.48, 95% confidence interval [CI] 0.42–0.55; p < 0.001), less current and lifetime smoking (OR 0.60, 95% CI 0.55–0.65; p < 0.001 and OR 0.75, 95% CI 0.71–0.79; p < 0.001), and less current alcohol consumption (OR 0.66, 95% CI 0.62–0.70; p < 0.001) compared with the general population. Prevalence of substance use was compared between CM and EM participants and showed higher illicit drug use (OR 1.73, 95% CI 1.11–2.69; p = 0.011), higher current smoking (OR 1.61, 95% CI 1.22–2.11; p < 0.001) but less alcohol use (OR 0.54, 95% CI 0.43–0.68; p < 0.001) for participants with CM compared with EM. No differences were found for a history of smoking (OR 1.18, 95% CI 0.92–1.50, p = 0.19).
Conclusions
Individuals with migraine are less likely to use illicit drugs, smoke, or drink alcohol compared with the general population. Patients with CM less often consume alcohol, while they more often use illicit drugs and smoke compared to those with EM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
ORCID-Profile: Iris E Verhagen
Zitieren
APA
van den Hoek, T. C., Verhagen, I. E., de Boer, I., & Terwindt, G. M. (2024). Substance use in a Dutch migraine cohort compared with the general population. Headache: The Journal of Head and Face Pain. https://doi.org/10.1111/head.14663
Vancouver
van den Hoek TC, Verhagen IE, de Boer I, Terwindt GM. Substance use in a Dutch migraine cohort compared with the general population. Headache: The Journal of Head and Face Pain. 2024. doi:10.1111/head.14663
BibTeX
@article{vandenHoek2024,
author = {van den Hoek, Thomas C and Verhagen, Iris E and de Boer, Irene and Terwindt, Gisela M},
title = {Substance use in a Dutch migraine cohort compared with the general population},
journal = {Headache: The Journal of Head and Face Pain},
year = {2024},
doi = {10.1111/head.14663}
}
EUVIMED